BIOCAD, CJSC ,   Russia

Antineoplastic agent, monoclonal antibodies

Concentrate for the preparation of a solution for infusions 12.5 mg / 0.5 ml, 100 mg / 4 ml and 400 mg / 16 ml.

Antiemetic means - serotonin receptor antagonist
Concentrate for solution for infusion, 1 mg / ml.
Cytokine
Solution for subcutaneous administration, 200 μg / ml.
An antineoplastic agent, an estrogen synthesis inhibitor.

Tablets, film-coated, 1 mg each.

Antitumor agent - antibodies monoclonal.
Concentrate for the preparation of a solution for infusions of 10 mg / ml.


Antitumor agent - antiandrogen

Tablets, film-coated, 50 mg.

Antitumor agent - antiandrogen

Tablets, film-coated, 150 mg.

Antitumor agent

Lyophilizate for the preparation of solution for intravenous and subcutaneous administration, 3.5 mg.

Antifungal agent
Liofilizate for the preparation of concentrate for the preparation of a solution for infusion 200 mg.
antitumor agent, antimetabolite.
Lyophilizate for the preparation of a solution for infusions of 200 mg, 1000 mg.
Immunomodulating agents, interferons

Suppositories 55 mg + 250,000 IU + 10 mg, 55 mg + 500,000 IU + 10 mg, 55 mg + 1000,000 IU + 10 mg.

Immunomodulating agents, interferons

Vaginal and rectal suppositories 125 000 IU + 5 mg and 250 000 IU + 5 mg.

Immunomodulating agent

Nasal drops 10 000 ME / ml + 0.8 mg / ml.

Immunomodulating agents, interferons
Spray nasal dosed 50 000 IU + 1 mg / dose.
Antiviral agent

The tablets covered with a film cover, 300 mg + 200 mg.

Antiviral [HIV] agent

Tablets, film-coated, 75 mg, 150 mg, 300 mg, 400 mg, 600 mg.

Means for treating HIV infection in combination

Tablets coated with a film coat 300.0 mg + 150.0 mg.

Inhibitor of bone resorption, bisphosphonate.

Concentrate for solution for infusion, 0.8 mg / ml.

antitumor agent, protein tyrosine kinase inhibitor
Tablets, film-coated, 50 mg, 100 mg.
Cytokine. Means for treating multiple sclerosis.

Solution for subcutaneous administration, 8 million IU / mL, 8 million IU / 0.5 mL.


Antitumor agent, alkaloid
Concentrate for the preparation of a solution for infusions of 20 mg / 4 ml and 100 mg / 5 ml (20 mg / ml).
Antitumour agent, antimetabolite

Film-coated tablets, 150 mg and 500 mg.

antitumor agent, alkylating compound

Concentrate for solution preparation for infusions, 10 mg / ml.

leukopoiesis stimulant

Solution for intravenous and subcutaneous administration, 300 μg / ml (30 million IU / ml).

leukopoiesis stimulant

Solution for intravenous and subcutaneous administration, 600 μg / ml (60 million IU / ml).

leukopoiesis stimulant

Solution for intravenous and subcutaneous administration, 300 μg / ml (30 million IU / ml).

antitumor agent - alkaloid

Concentrate for solution for infusion, 20 mg / ml.

antitumor agent - alkaloid

Concentrate for the preparation of a solution for infusions, 40 mg / ml.

Antifungal agent
Vaginal suppositories 300 mg / 10 mg.
Antitumour agent, antimetabolite

Lyophilizate for the preparation of a solution for infusions, 100 mg, 500 mg.

antitumor agent - alkylating compound

Liofilizate for the preparation of a solution for infusions, 50 mg and 100 mg.

An antitumour agent, an alkylating compound

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 150 mg, 200 mg.

Local anesthetic

Solution for injection 2 mg / ml, 5 mg / ml, 7.5 mg / ml, 10 mg / ml.

antitumor agent - alkaloid
Concentrate for solution preparation for infusions, 6 mg / ml.
Cytokine (Interferon beta-1a)

The solution for subcutaneous administration is 22 μg / 0.5 ml, 44 μg / 0.5 ml.

Capsules of 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg.5 capsules in a contour mesh box made of PVC film and aluminum foil. For 1 or 4 contour packs with instructions for use in a pack of cardboard.

Immunomodulating agent

A solution for subcutaneous administration of 20 mg / ml.

antitumour agent - antimetabolite

Tablets coated with a film coating, 10.0 mg.

antitumour agent - antimetabolite

Lyophilizate for the preparation of a solution for intravenous administration, 50 mg.

antitumor agent - alkaloid

Concentrate for solution for infusion, 10 mg / ml.

Leukopoiesis stimulant
RA mortar for subcutaneous administration, 7.5 mg / ml.
An antiviral drug active against HIV-1
capsules
Anticoagulant means of direct action

Solution for Injection 2000 anti-Ha IU / 0.2 ml; 4000 anti-Ha IU / 0.4 mL; 6000 anti-Ha IU / 0.6 mL; 8000 anti-Ha IU / 0.8 ml; 10,000 anti-Ha IU / 1 ml.

Antiviral agent

Tablets, film-coated, 0.5 mg and 1.0 mg.